Literature DB >> 22748765

Ligand-specific interactions modulate kinetic, energetic, and mechanical properties of the human β2 adrenergic receptor.

Michael Zocher1, Juan J Fung, Brian K Kobilka, Daniel J Müller.   

Abstract

G protein-coupled receptors (GPCRs) are a class of versatile proteins that transduce signals across membranes. Extracellular stimuli induce inter- and intramolecular interactions that change the functional state of GPCRs and activate intracellular messenger molecules. How these interactions are established and how they modulate the functional state of GPCRs remain to be understood. We used dynamic single-molecule force spectroscopy to investigate how ligand binding modulates the energy landscape of the human β2 adrenergic receptor (β2 AR). Five different ligands representing either agonists, inverse agonists or neutral antagonists established a complex network of interactions that tuned the kinetic, energetic, and mechanical properties of functionally important structural regions of β2 AR. These interactions were specific to the efficacy profile of the ligands investigated and suggest that the functional modulation of GPCRs follows structurally well-defined interaction patterns.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22748765      PMCID: PMC4506644          DOI: 10.1016/j.str.2012.05.010

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  57 in total

1.  Exploring the energy landscape of GFP by single-molecule mechanical experiments.

Authors:  Hendrik Dietz; Matthias Rief
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-05       Impact factor: 11.205

Review 2.  Transduction of receptor signals by beta-arrestins.

Authors:  Robert J Lefkowitz; Sudha K Shenoy
Journal:  Science       Date:  2005-04-22       Impact factor: 47.728

3.  Characterizing molecular interactions in different bacteriorhodopsin assemblies by single-molecule force spectroscopy.

Authors:  K Tanuj Sapra; Hüseyin Besir; Dieter Oesterhelt; Daniel J Muller
Journal:  J Mol Biol       Date:  2005-11-17       Impact factor: 5.469

4.  Locating ligand binding and activation of a single antiporter.

Authors:  Alexej Kedrov; Michael Krieg; Christine Ziegler; Werner Kuhlbrandt; Daniel J Muller
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

5.  Dynamic strength of molecular adhesion bonds.

Authors:  E Evans; K Ritchie
Journal:  Biophys J       Date:  1997-04       Impact factor: 4.033

Review 6.  G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition.

Authors:  J Wess
Journal:  FASEB J       Date:  1997-04       Impact factor: 5.191

Review 7.  Catecholamine receptors: structure, function, and regulation.

Authors:  M G Caron; R J Lefkowitz
Journal:  Recent Prog Horm Res       Date:  1993

8.  Entropic elasticity of lambda-phage DNA.

Authors:  C Bustamante; J F Marko; E D Siggia; S Smith
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

Review 9.  Beta 2 adrenergic receptors in asthma: a current perspective.

Authors:  T R Bai
Journal:  Lung       Date:  1992       Impact factor: 2.584

10.  Detecting molecular interactions that stabilize native bovine rhodopsin.

Authors:  K Tanuj Sapra; Paul S-H Park; Slawomir Filipek; Andreas Engel; Daniel J Müller; Krzysztof Palczewski
Journal:  J Mol Biol       Date:  2006-02-20       Impact factor: 5.469

View more
  40 in total

1.  Development and characterization of pepducins as Gs-biased allosteric agonists.

Authors:  Richard Carr; Yang Du; Julie Quoyer; Reynold A Panettieri; Jay M Janz; Michel Bouvier; Brian K Kobilka; Jeffrey L Benovic
Journal:  J Biol Chem       Date:  2014-11-13       Impact factor: 5.157

Review 2.  Structural approaches to understanding retinal proteins needed for vision.

Authors:  Tivadar Orban; Beata Jastrzebska; Krzysztof Palczewski
Journal:  Curr Opin Cell Biol       Date:  2013-11-28       Impact factor: 8.382

3.  Ligands raise the constraint that limits constitutive activation in G protein-coupled opioid receptors.

Authors:  Vanessa Vezzi; H Ongun Onaran; Paola Molinari; Remo Guerrini; Gianfranco Balboni; Girolamo Calò; Tommaso Costa
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

4.  Molecular modeling studies give hint for the existence of a symmetric hβ₂R-Gαβγ-homodimer.

Authors:  Andrea Straßer; Hans-Joachim Wittmann
Journal:  J Mol Model       Date:  2013-08-08       Impact factor: 1.810

5.  Kinetic, energetic, and mechanical differences between dark-state rhodopsin and opsin.

Authors:  Shiho Kawamura; Moritz Gerstung; Alejandro T Colozo; Jonne Helenius; Akiko Maeda; Niko Beerenwinkel; Paul S-H Park; Daniel J Müller
Journal:  Structure       Date:  2013-02-21       Impact factor: 5.006

Review 6.  Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptor.

Authors:  Anthony Yiu-Ho Woo; Ying Song; Weizhong Zhu; Rui-Ping Xiao
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

7.  Effect of material flexibility on the thermodynamics and kinetics of hydrophobically induced evaporation of water.

Authors:  Y Elia Altabet; Amir Haji-Akbari; Pablo G Debenedetti
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-13       Impact factor: 11.205

Review 8.  Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery.

Authors:  Louis M Luttrell
Journal:  Mol Endocrinol       Date:  2014-01-16

9.  P23H opsin knock-in mice reveal a novel step in retinal rod disc morphogenesis.

Authors:  Sanae Sakami; Alexander V Kolesnikov; Vladimir J Kefalov; Krzysztof Palczewski
Journal:  Hum Mol Genet       Date:  2013-11-07       Impact factor: 6.150

10.  Cholesterol increases kinetic, energetic, and mechanical stability of the human β2-adrenergic receptor.

Authors:  Michael Zocher; Cheng Zhang; Søren G F Rasmussen; Brian K Kobilka; Daniel J Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.